| 3.65 0 (0%) | 03-17 09:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.26 | 1-year : | 4.97 |
| Resists | First : | 3.65 | Second : | 4.26 |
| Pivot price | 3.64  |
|||
| Supports | First : | 3.6 |
Second : | 3.56 |
| MAs | MA(5) : | 3.65 | MA(20) : | 3.63 |
| MA(100) : | 3.18 |
MA(250) : | 2.59 |
|
| MACD | MACD : | 0  |
Signal : | 0 |
| %K %D | K(14,3) : | 100 | D(3) : | 100 |
| RSI | RSI(14): 77.9 | |||
| 52-week | High : | 3.65 | Low : | 1.35 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ QIPT ] has closed below upper band by 29.6%. Bollinger Bands are 95% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 52 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.66 - 3.68 | 3.68 - 3.69 |
| Low: | 3.6 - 3.62 | 3.62 - 3.64 |
| Close: | 3.62 - 3.65 | 3.65 - 3.68 |
Quipt Home Medical Corp., headquartered in Wilder, Kentucky, delivers essential medical devices and supplies directly to patients' homes across the United States. The company is dedicated to supporting individuals managing various chronic health conditions, such as cardiac and pulmonary diseases, sleep disorders, and reduced mobility, by supplying durable and respiratory medical equipment. Their extensive product catalog includes vital respiratory aids like oxygen concentrators, nebulizers, CPAP and BiPAP machines, and ventilator systems. Additionally, Quipt offers a broad selection of mobility assistance devices, including power wheelchairs, walkers, canes, crutches, and patient lifts. Other offerings span hospital beds, bariatric equipment, bathroom safety products, and wound care supplies. The company also provides rental options for specific respiratory apparatus. Established in 1993, the organization was known as Protech Home Medical Corp. until it rebranded to Quipt Home Medical Corp. in May 2021.
Wed, 22 Apr 2026
QIPT Financials: Income Statement, Balance Sheet & Cash Flow | Quipt Home Medical Corp - Stock Titan
Mon, 16 Mar 2026
Quipt Home Medical Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Mon, 16 Mar 2026
Home respiratory care firm Quipt taken private in $3.65-a-share deal - Stock Titan
Fri, 06 Mar 2026
Quipt to be acquired for US$3.65/share; delisting from TSX and NASDAQ expected - TradingView
Thu, 05 Mar 2026
Home respiratory care supplier Quipt set to go private in $3.65-a-share deal - Stock Titan
Tue, 30 Dec 2025
Quipt Home Medical Acquired, Becomes Privately Held Company - HME Business
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 44 (M) |
| Shares Float | 33 (M) |
| Held by Insiders | 21 (%) |
| Held by Institutions | 37.2 (%) |
| Shares Short | 699 (K) |
| Shares Short P.Month | 672 (K) |
| EPS | -0.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.28 |
| Profit Margin | -4.1 % |
| Operating Margin | 1.5 % |
| Return on Assets (ttm) | -0.9 % |
| Return on Equity (ttm) | -9.4 % |
| Qtrly Rev. Growth | 32 % |
| Gross Profit (p.s.) | 4.31 |
| Sales Per Share | 5.95 |
| EBITDA (p.s.) | 0.98 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 37 (M) |
| Levered Free Cash Flow | 45 (M) |
| PE Ratio | -15.87 |
| PEG Ratio | 0 |
| Price to Book value | 1.59 |
| Price to Sales | 0.61 |
| Price to Cash Flow | 4.34 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|